Name: PCI BIOTECH HOLDING ASA (PCIB) Stock
Brand: PCI BIOTECH HOLDING ASA
Rating: 3.5 (3 reviews)

Question 1

What does PCIB do?

Accepted Answer

PCI Biotech Holding ASA engages in the research and development of biopharmaceutical products for cancer treatment. The company is headquartered in Oslo, Oslo and currently employs 7 full-time employees. The company went IPO on 2008-06-18. The firm is developing therapeutic products based on its photochemical internalisation (PCI) technology. PCI Biotech’s product is the photosensitiser fimaporfin (Amphinex). The PCI technology can enhance the effect of anticancer drugs by targeted, light-directed drug delivery into cancer cells, and can also be used as a platform that may both potentiate the effect of vaccines and enable macromolecules to reach intracellular targets. The PCI technology platform consists of two elements: a small molecule photosensitiser (named fimaporfin) and a light source. The primary aim of PCI is to introduce drug molecules or macromolecules into the cytosol of the target cells. The company is this drug or macromolecule that gives the biological effect in a PCI treatment, and the intended biological effect may range from cell killing, through modification of gene expression to enhanced antigen presentation.

Question 2

What is the stock price of PCI BIOTECH HOLDING ASA today?

Accepted Answer

The current stock price of PCIB.OL is 0.26 NOK. The price increased by 14.54% in the last trading session.

Question 3

Does PCIB stock pay dividends?

Accepted Answer

PCIB.OL does not pay a dividend.

Question 4

What is the ChartMill rating of PCI BIOTECH HOLDING ASA stock?

Accepted Answer

PCIB.OL has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.

Question 5

Which stock exchange lists PCIB stock?

Accepted Answer

PCIB.OL stock is listed on the Euronext Oslo exchange.

Question 6

What is the GICS sector and industry of PCIB stock?

Accepted Answer

PCI BIOTECH HOLDING ASA (PCIB.OL) operates in the Health Care sector and the Biotechnology industry.

Question 7

Can you provide the market cap for PCI BIOTECH HOLDING ASA?

Accepted Answer

PCI BIOTECH HOLDING ASA (PCIB.OL) has a market capitalization of 9.71M NOK. This makes PCIB.OL a Nano Cap stock.

PCI BIOTECH HOLDING ASA (PCIB.OL) Stock Price, Forecast & Analysis

PCIB.OL Latest News, Press Relases and Analysis